Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept study from the PANTHEIA-SEOM trial

doi:10.4251/wjgo.v16.i2.386

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2484)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

WORD

HTML

1357

Figures (1-3)

288

Tables (1-5)

181

Sum=1907

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

127

Download

383

Sum=510

Feb 15, 2024 (publication date) through Dec 4, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastrointest Oncol. Feb 15, 2024; 16(2): 386-397
Published online Feb 15, 2024. doi: 10.4251/wjgo.v16.i2.386

Full Size Figure Download Figure

Figure 2 Kaplan-Meier curves illustrate overall survival for the entire cohort of patients with metastatic pancreatic cancer stratified by a weight loss cutoff of 5%.

Citation: Pacheco-Barcia V, Custodio-Cabello S, Carrasco-Valero F, Palka-Kotlowska M, Mariño-Mendez A, Carmona-Bayonas A, Gallego J, Martín AJM, Jimenez-Fonseca P, Cabezon-Gutierrez L. Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept study from the PANTHEIA-SEOM trial. World J Gastrointest Oncol 2024; 16(2): 386-397
URL: https://www.wjgnet.com/1948-5204/full/v16/i2/386.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i2.386